Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis
Frontiers in Pharmacology · 29.04.2026 · 17
DOI: 10.3389/fphar.2026.1728667 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.04.2026. Verfasst von Wenshuai Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Objectives
To evaluate the impact of point-of-care testing (POCT) on antibiotic prescribing and clinical outcomes in adult patients with community-acquired pneumonia (CAP) through a systematic review and meta-analysis.
Methods
Web of Science, Scopus, Embase, PubMed, and Cochrane Library were searched for randomized controlled trials (RCTs). The final search was conducted on June 2025. Outcomes included both antibiotic-related and clinical outcomes. The meta-analysis was performed using Review Manager. The study was registered with PROSPERO (CRD420251035572).
Results
Nine RCTs involving 2,899 participants were included. POCT significantly reduced the proportion of adult CAP patients receiving antibiotic prescriptions by 10% (RD = −0.10; 95% CI: −0.15 to −0.05, P < 0.0001) and shortened the duration of antibiotic treatment by 2.68 days (MD = −2.68; 95% CI: −4.41 to −0.95, P = 0.002). Available evidence suggests no signal of harm, although safety outcomes were reported in relatively few trials, such as the length of hospital stay (MD = −0.43; 95% CI: −1.41 to 0.54, P = 0.38). Sensitivity analyses confirmed the robustness of these findings.
Conclusion
POCT may reduce antibiotic exposure in patients with CAP without compromising clinical outcomes. As diagnostic innovation plays an increasingly important role in combating antimicrobial resistance, POCT should be used selectively as an adjunct to clinical judgment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China.
- Academy of Chinese Medical Sciences, The First Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, China.
- Co-Construction Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases by Henan & Education Ministry of P. R. China, Henan University of Chinese Medicine, Zhengzhou, China.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Ji, W., Xie, K., Zhang, K., Liang, Y., Wang, Y., Yang, H., Han, Y., Yin, W., & Wang, H. (2026). Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1728667
Vancouver
Ji W, Xie K, Zhang K, Liang Y, Wang Y, Yang H, et al. Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1728667
BibTeX
@article{Ji2026,
author = {Ji, Wenshuai and Xie, Kai and Zhang, Kang and Liang, Yingjin and Wang, Yikun and Yang, Hao and Han, Yifan and Yin, Wenjing and Wang, Haifeng},
title = {Point-of-care testing reduces antibiotic prescribing for adults with community-acquired pneumonia: a systematic review and meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1728667}
}
EUVIMED